J 2017

A head-to-head comparison of 4-L polyethylene glycol and low-volume solutions before colonoscopy: which is the best? A multicentre, randomized trial

KOJECKÝ, Vladimír; J. MATOUS; R. KEIL; Milan DASTYCH; Radek KROUPA et. al.

Basic information

Original name

A head-to-head comparison of 4-L polyethylene glycol and low-volume solutions before colonoscopy: which is the best? A multicentre, randomized trial

Authors

KOJECKÝ, Vladimír (203 Czech Republic); J. MATOUS (203 Czech Republic); R. KEIL (203 Czech Republic); Milan DASTYCH (203 Czech Republic, guarantor, belonging to the institution); Radek KROUPA (203 Czech Republic, belonging to the institution); Z. ZADOROVA (203 Czech Republic); M. VARGA (203 Czech Republic); Jiří DOLINA (203 Czech Republic, belonging to the institution); M. KMENT (203 Czech Republic) and Aleš HEP (203 Czech Republic, belonging to the institution)

Edition

International Journal of Colorectal Disease, New York, Springer, 2017, 0179-1958

Other information

Language

English

Type of outcome

Article in a journal

Field of Study

30219 Gastroenterology and hepatology

Country of publisher

United States of America

Confidentiality degree

is not subject to a state or trade secret

Impact factor

Impact factor: 2.533

RIV identification code

RIV/00216224:14110/17:00098392

Organization unit

Faculty of Medicine

UT WoS

000415692100014

EID Scopus

2-s2.0-85029905735

Keywords in English

Ascorbic acid; Colonoscopy; Magnesium citrate; Picosulfate sodium; Polyethylene glycol

Tags

Tags

International impact, Reviewed
Changed: 15/3/2018 17:06, Soňa Böhmová

Abstract

In the original language

Purpose: The purpose of this study is to compare the efficacy and tolerability of polyethylene glycol (PEG) to sodium picosulfate/magnesium citrate (SPMC) and low-volume polyethylene glycol/ascorbic acid (PEGA) in a single- or split-dose regimen for colonoscopy bowel preparation. Methods: This was a prospective, randomized, endoscopist-blinded, multicentre study. Outpatients received either PEG or SPMC or PEGA in a single or a split dose before the colonoscopy. Quality and tolerability of the preparation and complaints during preparation were recorded. Results: Nine hundred seventy-three patients were analysed. Satisfactory bowel cleansing (Aronchick score 1 + 2) was more frequent when a split dose was used irrespective of the solution type (PEG 90.1 vs 68.8%, PEGA 86.0 vs 71.6%, SPMC 84.3 vs 60.2%, p < 0.001). SPMC was the best tolerated followed by PEGA (p < 0.006) and PEG as the worst (p < 0.001). Tolerability did not correlate with the regimen and amount of the solution used. Female gender is associated with a higher incidence of nausea, vomiting and pain (p < 0.029). Conclusions: Both PEG, PEGA and SPMC are fully comparable in terms of colonic cleansing when used in similar regimens. The split-dose preparation is more effective in all agents. SPMC and PEGA are better tolerated than PEG. The preparation regimen and/or the volume do not affect tolerability.